Virtus Fund Advisers, LLC Cytokinetics Inc Transaction History

Virtus Fund Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$29.46 - $36.61 $7,040 - $8,749	239 Added 43.45%	789 $23,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $12,443 - $17,049	-373 Reduced 40.41%	550 $19,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $33,015 - $47,174	923 New	923 $42,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.64 Million - $2.33 Million	-42,645 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.25 - $15.65 $309,176 - $667,394	42,645	42,645 $348,000

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus Fund Advisers, LLC with notifications on news.